Join
Live feed
·
SECFilingvia Quantisnow
Kezar Life Sciences Inc. logo

Kezar Life Sciences Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Control of Registrant

ByQuantisnow·Wall Street's wire, on your screen.
KZR· Kezar Life Sciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KZR (Kezar Life Sciences Inc.) and more on Quantisnow.

Kezar Life Sciences Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Control of Registrant | Quantisnow